Pharmacological Characterization of GB1908, a Selective Galectin-1 Carbohydrate Binding Domain Inhibitor for the Treatment of CancerGB1908的药理学特性研究,GB1908是一种选择性半乳糖凝集素-1碳水化合物结合域抑制剂,用于癌症治疗PHARMACOLOGYIF3.22025-02-030PRE
The EGFR/ErbB inhibitor neratinib modifies the neutrophil phosphoproteome and promotes apoptosis and clearance by airway macrophagesFRONTIERS IN IMMUNOLOGYIF5.92022-07-286OAAI
Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammationELIFEIF02019-10-1526OA
The CXCL12/CXCR4 Signaling Axis Retains Neutrophils at Inflammatory Sites in ZebrafishFRONTIERS IN IMMUNOLOGYIF5.92019-07-3199OAAI